Pfizer Canada's exemestane [Aromasin] tablets have been granted a Notice of Compliance with Conditions by Health Canada.

Source: Inpharma, Volume 1, Number 1539, 2006-05-27 , pp. 23-23(1)

Publisher: Adis International

Keywords: Development-status; Early-breast-cancer, treatment; Exemestane, therapeutic use; Menopause; Product-approvals

Document Type: Short communication

Publication date: 2006-01-01

• In this: publication
• By this: publisher
• In this Subject: Pharmacology

Website © Publishing Technology. Article copyright remains with the publisher, society or author(s) as specified within the article.

• Terms and conditions
• Privacy policy
• Information for advertisers